Detailed Citric Acid, Mono. Description
Pharmaceutical: the product can be used as pharmaceutical intermediate,
treat rheumatoid, synthesized
with chondroitin sulphate as per stated proportioning, and similar rheumatoid arthritis; it also can be
processed N - 2-D - Glucosamine hydrocloride, the product can be directly used in producing pharmaceutical
planish pieces, effectively kill knub cell
growing, canned capsules etc.
Specifications:
a) Appearance: white to light yellow powder
b) Assay %: 99.0 min
c) Residue on lgnition %: 0.5 max
d) Loss on drying %: 0.5 max
e) Chloride %: 1.0 max
f) Iron ppm: 10 max
g) Heaxy metals ppm: 10 max
h) Arsenic ppm: 1 max
i) Specific rotation: 39.0 - 43.0o
j) Melting point : 196.0 - 205.0oC
k) Microbiological test
l) Total Plate Count: max 500 / g
m) Yeast and mold: max 100 / g
n) Salmonella: Negative
o) Coliforms: Negative
p) Package and storage: preserve in tight, light - resistant
containers
If you would like more information about Citric Acid, Mono., please contact us or visit our website for more details.
|
